Executive Management Team

 

 
Graham Mullis
Chief Executive Officer

 

  • Joined Lab21 January 2008
  • Over 25 years in healthcare; pharmaceuticals & medical devices
  • Internationally experienced leader with multi-disciplinary background
  • Both public (FTSE 250 & NASDAQ) and private companies
  • Experienced in M&A activity and MBO
  • Lived & worked in US and Singapore
Susan Lowther

Chief Financial Officer

  • Joined Lab21 July 2010
  • More than 20 years in pharmaceutical, biotech and healthcare industries
  • Public and private financing, including IPO and venture capital
  • Extensive financial management experience ranging from start-up rapid growth to global plcs
  • Experienced in M&A activity both acquisition and divestment
Dr Berwyn Clarke
Chief Scientific & Development Officer
  • Joined Lab21 April 2005
  • Founder and CEO of Oneida TheraDiagnostics Ltd
  • Over 25 years in pharmaceutical industry, Former Global Head of Virology Glaxo
  • Experience in both small and multi-national businesses
  • Leading HIV/HCV virologist
  • Significant involvement in both in and out licensing IP, acquisitions 
Dr Tony Cooke

Regulatory Compliance & Project Director

  • Joined Lab21 April 2005
  • PhD and BSc in Biology/Biochemistry
  • Trained ISO auditor & Lean manufacturing
  • Former MD of Monitoring Technologies Intl.
  • Former Operations Director of Acaris Healthcare Solutions
  • Previously with Celsis, ITL, Shimadzu and Palmer Bioscience Ltd
Mike Annable

Divisional Director: Clinical Lab

  • Joined Lab21 January 2008
  • More than 15 years experience in the Life Science sector
  • Experienced leader of Sales & Marketing teams in service, consumable and capital equipment markets
  • Former Sales Director at MWG-Biotech (UK)
  • Former General Manager at Hamilton Life Science Robotics (UK)
  • Experienced in business turn-around from loss to profit
  • Motivational team builder
Hayden Jeffreys

Divisional Director: Products

  • Joined Lab21 August 2008
  • More than 10 years diagnostic experience
  • Lived and worked in US
  • Held senior roles in molecular diagnostic and immunodiagnostic sector  including Gen-Probe & MLT Research
  • M&A experience
  • Commercial Director at Invitron Ltd
Michael Bolick

President, Lab21 Inc

  • Founded Selah Technologies LLC May 2006
  • Acquired by Lab21 December 2009
  • 18 years experience in starting and growing advanced materials manufacturing / life science focused companies
  • Serves on the National Cancer Institute’s SBIR Bridge Award Review Panel, the External Advisory Board of the University of South Carolina’s NanoCenter; and as Board President for South Carolina BIO, SC’s Life Science Industry Affiliate for the International BIO organization